Wells Fargo & Company Summit Therapeutics Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 200 shares of SMMT stock, worth $3,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200

Previous 34,082 99.41%

Holding current value

$3,642

Previous $265,000 98.49%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.89 - $31.93 $132,928 - $616,025	19,293 Added 56.61%	53,375 $1.17 Million
Q2 2024 Aug 13, 2024	SELL	$2.39 - $10.92 $13,515 - $61,752	-5,655 Reduced 14.23%	34,082 $265,000
Q1 2024 May 10, 2024	BUY	$2.55 - $5.07 $11,821 - $23,504	4,636 Added 13.21%	39,737 $164,000
Q4 2023 Feb 09, 2024	BUY	$1.67 - $2.83 $11,429 - $19,368	6,844 Added 24.22%	35,101 $91,000
Q3 2023 Nov 13, 2023	SELL	$1.54 - $2.42 $38,532 - $60,550	-25,021 Reduced 46.96%	28,257 $52,000
Q2 2023 Aug 15, 2023	BUY	$1.32 - $2.81 $63,424 - $135,017	48,049 Added 918.89%	53,278 $133,000
Q1 2023 May 12, 2023	SELL	$1.38 - $5.41 $658 - $2,580	-477 Reduced 8.36%	5,229 $9,000
Q4 2022 Feb 13, 2023	SELL	$0.68 - $5.31 $10,467 - $81,742	-15,394 Reduced 72.96%	5,706 $24,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.63 $178 - $326	200 Added 0.96%	21,100 $25,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.38 $20,871 - $53,992	-22,686 Reduced 52.05%	20,900 $21,000
Q1 2022 May 16, 2022	SELL	$2.0 - $3.45 $81,800 - $141,105	-40,900 Reduced 48.41%	43,586 $107,000
Q4 2021 Feb 14, 2022	SELL	$2.45 - $5.64 $226,806 - $522,117	-92,574 Reduced 52.28%	84,486 $227,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $8.27 $598,412 - $1.02 Million	123,895 Added 233.04%	177,060 $886,000
Q2 2021 Aug 16, 2021	BUY	$5.15 - $8.46 $9,089 - $14,931	1,765 Added 3.43%	53,165 $397,000
Q1 2021 May 13, 2021	BUY	$5.17 - $11.19 $33,088 - $71,616	6,400 Added 14.22%	51,400 $302,000
Q4 2020 Feb 09, 2021	BUY	$3.25 - $6.0 $32,500 - $60,000	10,000 Added 28.57%	45,000 $212,000
Q3 2020 Nov 05, 2020	BUY	$3.08 - $3.8 $107,800 - $133,000	35,000 New	35,000 $120,000

Others Institutions Holding SMMT

# of Institutions

192

Shares Held

75.8M

Call Options Held

2.01M

Put Options Held

2.84M

View Full List

About Summit Therapeutics Inc.

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.66B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

More about SMMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Summit Therapeutics Inc. Transaction History